Exosome-based therapy for epilepsy: a systematic review and meta-analysis of preclinical studies
Yongna Yang, Yinping Wu, Jianghua Si, Guolong Zhang, Liping Dong, Heng Liu, Chengyang Su, Zhilong Yang · 2026
Read Exosome-based therapy for epilepsy: a systematic review and meta-analysis of preclinical studies by Yongna Yang, Yinping Wu, Jianghua Si, Guolong Zhang, Liping Dong, Heng Liu, Chengyang Su, Zhilong Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13219301.txt.
Description
Yongna Yang and seven co-authors pooled animal studies to judge whether exosome treatment helps epilepsy, in this 2026 review and meta-analysis. Exosomes are tiny parcels that cells release, and they are being tried as a delivery route for calming brain inflammation. Single animal studies are small, so a pooled view can show whether the promise holds.
Eight studies qualified. Treated animals had shorter seizures, fewer repeat seizures, and a longer wait before seizures began. In maze tests they also remembered better, and their brains held more surviving neurons with lower levels of inflammation markers. Results varied between studies, and signs of publication bias appeared, though corrected effects stayed positive. The authors say dose, source, and delivery route need pinning down before human trials.
Catalog record
| CREATOR | Yongna Yang, Yinping Wu, Jianghua Si, Guolong Zhang, Liping Dong, Heng Liu, Chengyang Su, Zhilong Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |